“…In this context, the assessment of EDC exposure appears crucial in order to monitor populations at higher risk of exposure and to understand the link between exposure and adverse health effects. In biological samples concentrations of EDCs (e.g., bisphenol A (BPA), phthalates, parabens, polychlorinated biphenyls (PCBs), perfluorinated compounds, polybrominated diphenyl ethers) and metabolites of EDCs (e.g., metabolites of pyrethroids, insecticides, pesticides, phthalates) have been used as conventional biomarkers of exposure (Calsolaro et al 2017, Dziewirska et al 2018, Hampl et al 2016, Karwacka et al 2019). However, since 1995 (Sonnenschein et al 1995) some authors proposed novel biomarkers of exposure to EDCs, which focus on detecting the biological effect of chemical compounds or metabolites, rather than detecting the presence of the EDC itself.…”